Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2006 4
2007 7
2008 4
2009 3
2010 3
2011 3
2012 3
2013 4
2014 4
2015 1
2016 3
2017 2
2018 2
2019 3
2021 4
2022 1
2023 3
2024 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Ciclesonide, a hypotonic intranasal corticosteroid.
Neffen H, Wingertzahn MA. Neffen H, et al. Allergy Asthma Proc. 2010 May-Jun;31 Suppl 1:S29-37. doi: 10.2500/aap.2010.31.3348. Epub 2010 Jun 16. Allergy Asthma Proc. 2010. PMID: 20557684
Systemic exposure to ciclesonide and its active metabolite desisobutyryl-ciclesonide is low after intranasal administration. ...Thus, intranasal ciclesonide appears to provide an additional effective treatment option for patients with AR....
Systemic exposure to ciclesonide and its active metabolite desisobutyryl-ciclesonide is low after intranasal administra …
Inhaled and intranasal ciclesonide for the treatment of covid-19 in adult outpatients: CONTAIN phase II randomised controlled trial.
Ezer N, Belga S, Daneman N, Chan A, Smith BM, Daniels SA, Moran K, Besson C, Smyth LY, Bartlett SJ, Benedetti A, Martin JG, Lee TC, McDonald EG. Ezer N, et al. BMJ. 2021 Nov 2;375:e068060. doi: 10.1136/bmj-2021-068060. BMJ. 2021. PMID: 34728476 Free PMC article. Clinical Trial.
OBJECTIVE: To determine if inhaled and intranasal ciclesonide are superior to placebo at decreasing respiratory symptoms in adult outpatients with covid-19. ...INTERVENTION: Participants were randomised to receive either inhaled ciclesonide (600 mug twice dai …
OBJECTIVE: To determine if inhaled and intranasal ciclesonide are superior to placebo at decreasing respiratory symptoms in ad …
Comparison of intranasal ciclesonide, oral levocetirizine, and combination treatment for allergic rhinitis.
Kim CH, Kim JK, Kim HJ, Cho JH, Kim JS, Kim YD, Lee HM, Kim SW, Cho KS, Lee SH, Rhee CS, Dhong HJ, Rha KS, Yoon JH. Kim CH, et al. Allergy Asthma Immunol Res. 2015 Mar;7(2):158-66. doi: 10.4168/aair.2015.7.2.158. Epub 2014 Dec 18. Allergy Asthma Immunol Res. 2015. PMID: 25729623 Free PMC article.
PURPOSE: To evaluate the efficacy and safety of once-daily ciclesonide in comparison to both levocetirizine alone, and a ciclesonide/levocetirizine combination in patients with seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR). ...Addition of le …
PURPOSE: To evaluate the efficacy and safety of once-daily ciclesonide in comparison to both levocetirizine alone, and a ciclesoni …
Intranasal ciclesonide for allergic rhinitis.
Williams B, Smith WB, Kette FE. Williams B, et al. J Asthma Allergy. 2008 Nov 30;1:49-54. doi: 10.2147/jaa.s3082. J Asthma Allergy. 2008. PMID: 21436985 Free PMC article.
Ciclesonide is a novel corticosteroid which is optimized for topical use. It is a pro-drug which is activated locally in the airway mucosa, lipid-conjugated for local retention, and has very high protein binding in circulation leading to low systemic bioavailability. ...Ho …
Ciclesonide is a novel corticosteroid which is optimized for topical use. It is a pro-drug which is activated locally in the airway m …
Ciclesonide nasal spray: in allergic rhinitis.
Dhillon S, Wagstaff AJ. Dhillon S, et al. Drugs. 2008;68(6):875-83. doi: 10.2165/00003495-200868060-00009. Drugs. 2008. PMID: 18416590 Review.
Ciclesonide nasal spray delivers the corticosteroid ciclesonide as a hypotonic spray via a metered-dose manual pump. Systemic exposure to ciclesonide and its active metabolite desisobutyryl-ciclesonide is low after intranasal administration. ...
Ciclesonide nasal spray delivers the corticosteroid ciclesonide as a hypotonic spray via a metered-dose manual pump. Systemic …
Safety of intranasal corticosteroid sprays during pregnancy: an updated review.
Alhussien AH, Alhedaithy RA, Alsaleh SA. Alhussien AH, et al. Eur Arch Otorhinolaryngol. 2018 Feb;275(2):325-333. doi: 10.1007/s00405-017-4785-3. Epub 2017 Nov 21. Eur Arch Otorhinolaryngol. 2018. PMID: 29164323 Review.
OBJECTIVE: To review the current literature about the safety of intranasal corticosteroid sprays during pregnancy. METHODOLOGY: Using different search engines, each type of INCS was reviewed separately (triamcinolone, beclomethasone, budesonide, fluticasone propionate, flu …
OBJECTIVE: To review the current literature about the safety of intranasal corticosteroid sprays during pregnancy. METHODOLOGY: Using …
Intranasal corticosteroids in the treatment of allergic rhinitis.
Ratner PH, Stoloff S, Meltzer EO, Hadley JA. Ratner PH, et al. Allergy Asthma Proc. 2007 May-Jun;28 Suppl 1:S25-32. doi: 10.2500/aap.2007.28.2994. Allergy Asthma Proc. 2007. PMID: 18307841 Review.
Moreover, the results of two clinical trials, including a 52-week study, have suggested that intranasal ciclesonide does not cause cortisol suppression. Furthermore, intranasal ciclesonide does not have an additive effect on the hypothalamic-pituitary- …
Moreover, the results of two clinical trials, including a 52-week study, have suggested that intranasal ciclesonide does not c …
New intranasal formulations for the treatment of allergic rhinitis.
Meltzer EO, Bensch GW, Storms WW. Meltzer EO, et al. Allergy Asthma Proc. 2014 May-Jun;35 Suppl 1:S11-9. doi: 10.2500/aap.2014.35.3756. Allergy Asthma Proc. 2014. PMID: 25582157 Review.
Intranasal corticosteroids (INSs) have been effectively used for >40 years for the treatment of seasonal allergic rhinitis (SAR) and perennial AR (PAR). ...Food and Drug Administration approved two new nonaqueous aerosol AR treatments that use a hydrofluoroalkane (HFA) …
Intranasal corticosteroids (INSs) have been effectively used for >40 years for the treatment of seasonal allergic rhinitis (SAR) a …
Comparative efficacy and acceptability of licensed dose intranasal corticosteroids for moderate-to-severe allergic rhinitis: a systematic review and network meta-analysis.
Soe KK, Krikeerati T, Pheerapanyawaranun C, Niyomnaitham S, Phinyo P, Thongngarm T. Soe KK, et al. Front Pharmacol. 2023 May 23;14:1184552. doi: 10.3389/fphar.2023.1184552. eCollection 2023. Front Pharmacol. 2023. PMID: 37288109 Free PMC article. Review.
No evidence shows that one intranasal corticosteroid (INCS) is better than another for treating moderate-to-severe allergic rhinitis (AR). ...In seasonal AR, mometasone furoate (MF) was ranked the highest efficacy, followed by fluticasone furoate (FF), ciclesonide ( …
No evidence shows that one intranasal corticosteroid (INCS) is better than another for treating moderate-to-severe allergic rhinitis …
53 results